CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10.
Multisystem inflammatory syndrome in children (MIS-C) is a newly identified and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations vary widely among patients with MIS-C, and the aim of this study was to investigate factors associated with severe outcomes.
In this retrospective surveillance study, patients who met the US Centers for Disease Control and Prevention (CDC) case definition for MIS-C (younger than 21 years, fever, laboratory evidence of inflammation, admitted to hospital, multisystem [≥2] organ involvement [cardiac, renal, respiratory, haematological, gastrointestinal, dermatological, or neurological], no alternative plausible diagnosis, and either laboratory confirmation of SARS-CoV-2 infection by RT-PCR, serology, or antigen test, or known COVID-19 exposure within 4 weeks before symptom onset) were reported from state and local health departments to the CDC using standard case-report forms. Factors assessed for potential links to severe outcomes included pre-existing patient factors (sex, age, race or ethnicity, obesity, and MIS-C symptom onset date before June 1, 2020) and clinical findings (signs or symptoms and laboratory markers). Logistic regression models, adjusted for all pre-existing factors, were used to estimate odds ratios between potential explanatory factors and the following outcomes: intensive care unit (ICU) admission, shock, decreased cardiac function, myocarditis, and coronary artery abnormalities.
1080 patients met the CDC case definition for MIS-C and had symptom onset between March 11 and Oct 10, 2020. ICU admission was more likely in patients aged 6-12 years (adjusted odds ratio 1·9 [95% CI 1·4-2·6) and patients aged 13-20 years (2·6 [1·8-3·8]), compared with patients aged 0-5 years, and more likely in non-Hispanic Black patients, compared with non-Hispanic White patients (1·6 [1·0-2·4]). ICU admission was more likely for patients with shortness of breath (1·9 [1·2-2·9]), abdominal pain (1·7 [1·2-2·7]), and patients with increased concentrations of C-reactive protein, troponin, ferritin, D-dimer, brain natriuretic peptide (BNP), N-terminal pro B-type BNP, or interleukin-6, or reduced platelet or lymphocyte counts. We found similar associations for decreased cardiac function, shock, and myocarditis. Coronary artery abnormalities were more common in male patients (1·5 [1·1-2·1]) than in female patients and patients with mucocutaneous lesions (2·2 [1·3-3·5]) or conjunctival injection (2·3 [1·4-3·7]).
Identification of important demographic and clinical characteristics could aid in early recognition and prompt management of severe outcomes for patients with MIS-C.
None.
儿童多系统炎症综合征(MIS-C)是一种与 SARS-CoV-2 感染相关的新确定的严重健康状况。MIS-C 患者的临床表现差异很大,本研究旨在调查与严重结局相关的因素。
在这项回顾性监测研究中,符合美国疾病控制与预防中心(CDC)MIS-C 病例定义的患者(年龄小于 21 岁,发热,有炎症的实验室证据,住院,多系统[≥2]器官受累[心脏、肾脏、呼吸、血液、胃肠道、皮肤或神经],无其他合理的诊断,且通过 RT-PCR、血清学或抗原检测实验室确认 SARS-CoV-2 感染,或在症状出现前 4 周内已知 COVID-19 接触)通过标准病例报告表向 CDC 报告来自州和地方卫生部门。评估了与严重结局潜在关联的因素包括患者的固有因素(性别、年龄、种族或民族、肥胖症和 MIS-C 症状出现日期早于 2020 年 6 月 1 日)和临床发现(体征或症状和实验室标志物)。使用调整所有固有因素的逻辑回归模型来估计潜在解释因素与以下结局之间的比值比:重症监护病房(ICU)入院、休克、心功能下降、心肌炎和冠状动脉异常。
1080 名患者符合 CDC 的 MIS-C 病例定义,症状出现于 2020 年 3 月 11 日至 10 月 10 日之间。与 0-5 岁患者相比,6-12 岁(调整后的比值比 1.9 [95%CI 1.4-2.6)和 13-20 岁(2.6 [1.8-3.8)患者更有可能入住 ICU;与非西班牙裔白人患者相比,非西班牙裔黑人患者更有可能入住 ICU(1.6 [1.0-2.4)。呼吸急促(1.9 [1.2-2.9])、腹痛(1.7 [1.2-2.7])、C 反应蛋白、肌钙蛋白、铁蛋白、D-二聚体、脑钠肽(BNP)、氨基末端 B 型利钠肽前体(NT-proBNP)或白细胞介素-6 浓度升高,血小板或淋巴细胞计数减少的患者更有可能入住 ICU。我们发现心功能下降、休克和心肌炎也存在类似的关联。与女性患者(1.5 [1.1-2.1)相比,男性患者(1.5 [1.1-2.1)更有可能出现冠状动脉异常,与有粘膜皮肤病变(2.2 [1.3-3.5)或结膜充血(2.3 [1.4-3.7)的患者相比,男性患者更有可能出现冠状动脉异常。
识别重要的人口统计学和临床特征可有助于早期识别和及时治疗 MIS-C 患者的严重结局。
无。